Clinical Trial Update: Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing short-course isoniazid plus rifampin versus isoniazid alone for latent tuberculosis infection was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis Infection
• Tuberculosis

Drugs mentioned

• ISONIAZID (ISONIAZID)
• RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: Hospital Virgen de la Luz | Conditions: Tuberculosis | Phase 4 | Status: TERMINATED